San Francisco Sentry Investment Group CA Acquires 216 Shares of Aetna Inc. (AET)
San Francisco Sentry Investment Group CA lifted its holdings in Aetna Inc. (NYSE:AET) by 10.4% during the second quarter, according to the company in its most recent filing with the SEC. The fund owned 2,290 shares of the company’s stock after buying an additional 216 shares during the quarter. San Francisco Sentry Investment Group CA’s holdings in Aetna were worth $347,000 as of its most recent filing with the SEC.
Other institutional investors have also bought and sold shares of the company. Bruderman Asset Management LLC bought a new position in shares of Aetna in the 2nd quarter worth about $106,000. Liberty Capital Management Inc. lifted its position in shares of Aetna by 206.9% in the 2nd quarter. Liberty Capital Management Inc. now owns 933 shares of the company’s stock worth $144,000 after buying an additional 629 shares during the last quarter. Deschutes Portfolio Strategy LLC bought a new position in shares of Aetna in the 2nd quarter worth about $200,000. Institute for Wealth Management LLC. bought a new position in shares of Aetna in the 2nd quarter worth about $201,000. Finally, Guardian Life Insurance Co. of America lifted its position in shares of Aetna by 0.7% in the 1st quarter. Guardian Life Insurance Co. of America now owns 1,353 shares of the company’s stock worth $173,000 after buying an additional 9 shares during the last quarter. Institutional investors own 89.52% of the company’s stock.
In other Aetna news, President Karen S. Lynch sold 15,271 shares of the stock in a transaction on Monday, September 18th. The stock was sold at an average price of $161.91, for a total transaction of $2,472,527.61. Following the transaction, the president now owns 64,261 shares in the company, valued at approximately $10,404,498.51. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Margaret M. Mccarthy sold 10,288 shares of the stock in a transaction on Friday, September 15th. The stock was sold at an average price of $162.85, for a total value of $1,675,400.80. Following the transaction, the executive vice president now owns 33,563 shares in the company, valued at approximately $5,465,734.55. The disclosure for this sale can be found here. Company insiders own 0.90% of the company’s stock.
Aetna Inc. (NYSE AET) traded down 1.01% during trading on Thursday, reaching $161.56. 397,033 shares of the company’s stock traded hands. The firm’s 50 day moving average is $157.93 and its 200-day moving average is $147.55. The company has a market capitalization of $53.65 billion, a price-to-earnings ratio of 35.86 and a beta of 0.53. Aetna Inc. has a 12 month low of $104.59 and a 12 month high of $164.52.
Aetna (NYSE:AET) last announced its quarterly earnings results on Thursday, August 3rd. The company reported $3.42 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.34 by $1.08. Aetna had a return on equity of 20.52% and a net margin of 2.52%. The business had revenue of $15.52 billion during the quarter, compared to the consensus estimate of $15.34 billion. During the same quarter last year, the firm posted $2.21 EPS. The company’s quarterly revenue was down 2.7% on a year-over-year basis. Analysts expect that Aetna Inc. will post $9.55 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Thursday, October 12th will be issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 1.23%. The ex-dividend date of this dividend is Wednesday, October 11th. Aetna’s dividend payout ratio is 43.67%.
A number of research analysts have recently issued reports on the stock. Argus restated a “buy” rating and issued a $185.00 price target (up from $165.00) on shares of Aetna in a research report on Tuesday, September 12th. Zacks Investment Research downgraded shares of Aetna from a “buy” rating to a “hold” rating in a research report on Tuesday. Royal Bank Of Canada raised their price target on shares of Aetna from $162.00 to $171.00 and gave the stock an “outperform” rating in a research report on Friday, August 4th. Deutsche Bank AG raised their price target on shares of Aetna from $157.00 to $163.00 and gave the stock a “hold” rating in a research report on Monday, August 7th. Finally, Jefferies Group LLC restated a “hold” rating and issued a $163.00 price target (up from $157.00) on shares of Aetna in a research report on Friday, August 4th. Eight investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $160.77.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.